Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes

Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?

NCT01040819 ·Status: COMPLETED ·Phase: PHASE4

Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus

NCT00545857 ·Status: COMPLETED ·Phase: PHASE1

Effect of Thiazolidinedione Treatment Vascular Risk Markers

NCT00571506 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

NCT04885712 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy

NCT03499704 ·Status: COMPLETED ·Phase: PHASE4

Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin

NCT00576784 ·Status: COMPLETED ·Phase: PHASE4

SGLT2i, Pioglitazone, and Ketone Production in T2D

NCT07053319 ·Status: RECRUITING ·Phase: PHASE1

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

NCT00286494 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

NCT00772174 ·Status: COMPLETED ·Phase: PHASE3

Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients

NCT00189774 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients

NCT00399204 ·Status: WITHDRAWN ·Phase: PHASE4

Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.

NCT00770653 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus

NCT01294423 ·Status: COMPLETED ·Phase: PHASE3

Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.

NCT02157298 ·Status: COMPLETED ·Phase: PHASE4

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

NCT00331487 ·Status: COMPLETED ·Phase: PHASE3

Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

NCT01990300 ·Status: COMPLETED

Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease

NCT00513630 ·Status: COMPLETED ·Phase: PHASE4

Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes

NCT00991055 ·Status: UNKNOWN ·Phase: PHASE4

Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

NCT01947790 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

NCT00754403 ·Status: COMPLETED ·Phase: PHASE4

Role of Pioglitazone in Preventing Diabetes

NCT00276497 ·Status: COMPLETED ·Phase: PHASE1

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

NCT00086502 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy

NCT00515632 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19

NCT04535700 ·Status: COMPLETED ·Phase: PHASE4

Effect of Pioglitazone Therapy for Type 2 Diabetes on Vision

NCT00548158 ·Status: COMPLETED